Roche Pharma (Switzerland) AG
- L01 - Antineoplásicos
- ALECENSA capsule, hard 150 mg
- L04 - Inmunosupresores
- ACTEMRA concentrate for solution for infusion 200 mg/10 ml
- ACTEMRA concentrate for solution for infusion 400 mg/20 ml
- ACTEMRA concentrate for solution for infusion 80 mg/4 ml
- ACTEMRA PREFILLED PEN solution for injection 162 mg/0.9 ml
- ACTEMRA PREFILLED SYRINGE solution for injection 162 mg/0.9 ml